Correlation Between NioCorp Developments and Tandem Diabetes
Can any of the company-specific risk be diversified away by investing in both NioCorp Developments and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NioCorp Developments and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NioCorp Developments Ltd and Tandem Diabetes Care, you can compare the effects of market volatilities on NioCorp Developments and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NioCorp Developments with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of NioCorp Developments and Tandem Diabetes.
Diversification Opportunities for NioCorp Developments and Tandem Diabetes
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NioCorp and Tandem is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding NioCorp Developments Ltd and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and NioCorp Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NioCorp Developments Ltd are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of NioCorp Developments i.e., NioCorp Developments and Tandem Diabetes go up and down completely randomly.
Pair Corralation between NioCorp Developments and Tandem Diabetes
Allowing for the 90-day total investment horizon NioCorp Developments Ltd is expected to generate 9.0 times more return on investment than Tandem Diabetes. However, NioCorp Developments is 9.0 times more volatile than Tandem Diabetes Care. It trades about 0.04 of its potential returns per unit of risk. Tandem Diabetes Care is currently generating about 0.01 per unit of risk. If you would invest 81.00 in NioCorp Developments Ltd on August 27, 2024 and sell it today you would earn a total of 58.00 from holding NioCorp Developments Ltd or generate 71.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NioCorp Developments Ltd vs. Tandem Diabetes Care
Performance |
| Timeline |
| NioCorp Developments |
| Tandem Diabetes Care |
NioCorp Developments and Tandem Diabetes Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NioCorp Developments and Tandem Diabetes
The main advantage of trading using opposite NioCorp Developments and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NioCorp Developments position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.| NioCorp Developments vs. Vale SA ADR | NioCorp Developments vs. Teck Resources Ltd | NioCorp Developments vs. BHP Group Limited | NioCorp Developments vs. Glencore PLC ADR |
| Tandem Diabetes vs. DexCom Inc | Tandem Diabetes vs. Inspire Medical Systems | Tandem Diabetes vs. Penumbra | Tandem Diabetes vs. Insulet |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |